HomeNewsIndiaCentre moves SC seeking extension of time for framing guidelines for ex-gratia

Centre moves SC seeking extension of time for framing guidelines for ex-gratia

The Centre in an application said that the exercise which was in active consideration of the NDMA was at an advance stage and requires a little more in-depth examination.

July 20, 2021 / 20:10 IST

The Centre has moved the Supreme Court seeking extension of time granted by the apex court to the National Disaster Management Authority (NDMA) to frame guidelines for ex-gratia compensation to families of those who died of COVID-19 by another four weeks.

The apex court had in its June 30 verdict directed NDMA to recommend within six weeks appropriate guidelines for ex-gratia assistance on account of loss of life to the family members of persons who died due to COVID-19.

The Centre in an application said that the exercise which was in active consideration of the NDMA was at an advance stage and requires a little more in-depth examination.

Applicant (Union of India) respectfully submits that exercise to frame appropriate guidelines for payment of ex-gratia payment to the victims of COVID-19 disaster under section 12 (iii) of the DMA (Disaster Management Act) is in active consideration of the NDMA and going on, said the plea, drawn by advocate Rajat Nair.

It is submitted this exercise, though at an active advance stage, requires a little more in-depth examination before the same is finalised and implemented. Any accelerated formulation, in the respectful submission of the applicant, may result into undesirable results, it said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The Centre urged the top court to grant another four weeks to frame the guidelines.

In its June 30 verdict, the top court had also ordered steps to simplify guidelines for issuance and correction of death certificates/official documents stating the exact cause of death, that is, 'Death due to Covid-19' for enabling dependents to get benefits of welfare schemes.

The apex court, however, had noted the peculiarity and the impact and effect of the pandemic and said that it cannot order payment of Rs 4 lakh as ex-gratia compensation which should be decided by the NDMA as there was a need to focus simultaneously on prevention, preparedness, mitigation and recovery, which calls for a different order of mobilization of both financial and technical resources.

We direct the NDMA to recommend guidelines for ex gratia assistance on account of loss of life to the family members of the persons who died due to Covid-19, as mandated under Section 12(iii) of Disaster Management Act (DMA) 2005 for the minimum standards of relief to be provided to the persons affected by disaster Covid 19 Pandemic, over and above the guidelines already recommended for the minimum standards of relief to be provided to persons affected by Covid-19, it had said.

It had also directed the Centre to take appropriate steps on recommendations of the Finance Commission on providing insurance cover for deaths caused by Covid.

The direction had come after the Centre said that presently there was no guideline/policy/scheme in NDMA which relates to National Insurance mechanism that may be used to pay for disaster related deaths due to COVID.

The top court's verdict had come on two separate pleas filed by lawyers Reepak Kansal and Gaurav Kumar Bansal seeking directions to the Centre and the states to provide Rs 4 lakh compensation to the families of coronavirus victims as provisioned under the Act.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: Jul 20, 2021 08:10 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347